Antiviral | Low Risk

tenofovir disoproxil (Tenofovir Sandoz)

What to know about tenofovir disoproxil — also sold as Tenofovir Sandoz, TENOFOVIR ARX, Viread, Tenofovir GH, Tenofovir Disoproxil Viatris: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.

tenofovir disoproxil (brand names: Tenofovir Sandoz, TENOFOVIR ARX, Viread, Tenofovir GH, Tenofovir Disoproxil Viatris) is classified as Low risk (1 risk points) by AllMeds. It is a S4 medication under the TGA in Australia. HIV antiviral with minimal occupational safety concerns.

Key Takeaways

  • TGA Schedule: S4 in Australia
  • Risk level: Low (1 points)
  • PBS listed: Subsidised under the Australian Pharmaceutical Benefits Scheme

Scheduling and Classification

Jurisdiction Classification Status
Australia (TGA) S4 PBS listed

Risk Profile

Risk Level Low
Risk Points 1
CNS Depressant No
Respiratory Risk No

HIV antiviral with minimal occupational safety concerns.

How tenofovir disoproxil is regulated

tenofovir disoproxil is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.

Australia TGA / PBS / State Schemes

Classified as S4 under the Therapeutic Goods Administration (TGA).

Listed on the Pharmaceutical Benefits Scheme (PBS) for subsidised prescribing.

Check this medication against your full medication list

Run a full risk assessment including tenofovir disoproxil interactions and compliance checks.

Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.

Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.